Tag: Parkinson’s

January 27, 2020 Off

Affiris to proceed with P2study with lead treatment for Parkinson’s

By Dino Mustafić

AFFiRiS AG, a clinical-stage biopharmaceutical company developing novel disease-modifying specific active immunotherapies (SAITs) for patients with neurodegenerative diseases, will proceed with the preparations for the planned phase 2 study and confirms its intended initiation in the US and Europe in the second half of 2020.